GOLD ABE Assessment (COPD Group A/B/E)
GOLD ABE Assessment (COPD Group A/B/E) - a deterministic tool in Sophie Well's Clinical Scoring & Risk group.
Open the GOLD ABE Assessment (COPD Group A/B/E) → Runs in your browser. No signup, no tracking.
What this is
GOLD ABE Assessment (COPD Group A/B/E) is one of 230 deterministic tools in Sophie Well's Clinical Scoring & Risk group. GOLD ABE Assessment (COPD Group A/B/E) - a deterministic tool in Sophie Well's Clinical Scoring & Risk group.
When to use it
Use this tool when you need a quick, citable reference. Every calculation runs entirely in your browser - no inputs leave your device, no account is required, no AI is involved. The site enforces a strict Content Security Policy and ships no analytics or third-party CDN.
References
Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Prevention, Diagnosis and Management of COPD: 2025 Report. The ABE assessment tool (symptoms + exacerbation history). Read the source ↗
Worked example: Group B — more symptoms (mMRC 2 >= 2) with low future-exacerbation risk (1 moderate exacerbation, none hospitalized in the past year).
Sophie Well is a reference and educational tool. Not medical, legal, or financial advice. Does not replace clinician judgment, professional billing review, or legal counsel.